DuPont ups glycolic acid production
This article was originally published in The Rose Sheet
Executive Summary
In response to growing demand for glycolic acid, DuPont Chemical Solutions Enterprise announces $18 mil. capacity expansion at its manufacturing facility in West Virginia that will increase production of the ingredient by 45%, firm says July 15. Facility is already the world's largest glycolic acid plant, DuPont notes. "The success of this business is reflected in its double-digit growth year over year for the past five years. We want to ensure that we will be able to continue to meet current and future demand for this versatile product used in so many different applications," says Paolo Barbieri, global business director, clean and disinfect. Firm markets cosmetic-grade glycolic acid, Glypure, to the personal-care sector...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.